Anthera Pharmaceuticals, Inc. – OTC:ANTH

Anthera Pharmaceuticals stock price today

$0
-0.00
-50%
Financial Health
0
1
2
3
4
5
6
7
8
9

Anthera Pharmaceuticals stock price monthly change

-100.00%
month

Anthera Pharmaceuticals stock price quarterly change

-100.00%
quarter

Anthera Pharmaceuticals stock price yearly change

-100.00%
year

Anthera Pharmaceuticals key metrics

Market Cap
 617.83K
Enterprise value
 N/A
P/E
 -0.01
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -0.46
Revenue
 N/A
EBITDA
 -49.92M
Income
 -9.86M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Anthera Pharmaceuticals stock price history

Anthera Pharmaceuticals stock forecast

Anthera Pharmaceuticals financial statements

Profit Margin

Anthera Pharmaceuticals, Inc. (OTC:ANTH): Profit margin
Jun 2017 0 9.28M
Sep 2017 0 -4.65M
Dec 2017 0 -10.05M
Mar 2018 0 -4.43M
ANTH income statement history

Quarterly Earnings

Anthera Pharmaceuticals, Inc. (OTC:ANTH): Earnings per share (EPS)
2017-08-09 -1.09 0.03
2017-11-06 -0.91 -0.58
2018-03-05 -0.66 -0.73
2018-05-15 -0.55 -0.57
ANTH earnings history

Debt to Assets

Anthera Pharmaceuticals, Inc. (OTC:ANTH): Debt to assets
Jun 2017 14506000 9.94M 68.58%
Sep 2017 8368000 8.02M 95.9%
Dec 2017 3673000 9.16M 249.61%
Mar 2018 8811000 3.35M 38.02%
ANTH balance sheet history

Cash Flow

Anthera Pharmaceuticals, Inc. (OTC:ANTH): Cash Flow
Jun 2017 -10.11M 0 612K
Sep 2017 -6.19M 0 1.12M
Dec 2017 -6.26M 0 2.38M
Mar 2018 -9.38M 358K 14.91M
ANTH cash flow history

Anthera Pharmaceuticals alternative data

Anthera Pharmaceuticals
Employees

Anthera Pharmaceuticals, Inc. (OTC:ANTH): Employee count
Aug 2023 21
Sep 2023 21
Oct 2023 21
Nov 2023 21
Dec 2023 21
Jan 2024 21
Feb 2024 21
Mar 2024 21
Apr 2024 21
May 2024 21
Jun 2024 21
Jul 2024 21

Anthera Pharmaceuticals other data

Anthera Pharmaceuticals
Insider Trading

Anthera Pharmaceuticals, Inc. (OTC:ANTH): Insider trades (number of shares)
Period Buy Sel
Sep 2017 23950 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
THOMPSON JOHN CRAIG director, officer.. Common stock 8,550 $1.32 $11,286
Purchase
THOMPSON JOHN CRAIG director, officer.. Common stock 10,400 $1.43 $14,893
Purchase
TRUEX PAUL F director Common Stock 5,000 $1.34 $6,700
Option
THOMPSON JOHN CRAIG director, officer.. Common stock 10,400 $1.43 $14,893
Option
TRUEX PAUL F director Common stock 5,008 $2.08 $10,417
Option
MUELLER BRIAN director Common stock 10,000 $2.89 $28,900
Option
HISLOP COLIN officer: Chief Medical Officer
 Common Stock 12,500 $1.61 $20,125
Sale
HISLOP COLIN officer: Chief Medical Officer
 Common Stock 12,500 $1.61 $20,125
Sale
HISLOP COLIN officer: Chief Medical Officer
 Common Stock 5,000 $5.38 $26,900
Sale
ODINK DEBRA officer: Chief Technology Officer
 Common Stock 1,205 $6.15 $7,411
ANTH insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of Anthera Pharmaceuticals stock today?

    One share of Anthera Pharmaceuticals stock can currently be purchased for approximately $0.

  • When is Anthera Pharmaceuticals's next earnings date?

    Unfortunately, Anthera Pharmaceuticals's (ANTH) next earnings date is currently unknown.

  • Does Anthera Pharmaceuticals pay dividends?

    No, Anthera Pharmaceuticals does not pay dividends.

  • How much money does Anthera Pharmaceuticals make?

    Anthera Pharmaceuticals has a market capitalization of 617.83K.

  • What is Anthera Pharmaceuticals's stock symbol?

    Anthera Pharmaceuticals, Inc. is traded on the OTC under the ticker symbol "ANTH".

  • What is Anthera Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Anthera Pharmaceuticals?

    Shares of Anthera Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Anthera Pharmaceuticals's key executives?

    Anthera Pharmaceuticals's management team includes the following people:

    • Mr. John Craig Thompson Chief Executive Officer & Director(age: 58, pay: $715,300)
    • Mr. Paul F. Truex Executive Chairman(age: 56, pay: $100,000)

  • How many employees does Anthera Pharmaceuticals have?

    As Jul 2024, Anthera Pharmaceuticals employs 21 workers.

  • When Anthera Pharmaceuticals went public?

    Anthera Pharmaceuticals, Inc. is publicly traded company for more then 15 years since IPO on 1 Mar 2010.

  • What is Anthera Pharmaceuticals's official website?

    The official website for Anthera Pharmaceuticals is anthera.com.

  • Where are Anthera Pharmaceuticals's headquarters?

    Anthera Pharmaceuticals is headquartered at The Pennzoil Building, Houston, TX.

  • How can i contact Anthera Pharmaceuticals?

    Anthera Pharmaceuticals's mailing address is The Pennzoil Building, Houston, TX and company can be reached via phone at +41 03501839.

Anthera Pharmaceuticals company profile:

Anthera Pharmaceuticals, Inc.

anthera.com
Exchange:

OTC

Full time employees:

21

Industry:

Biotechnology

Sector:

Healthcare

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.

+41 03501839
The Pennzoil Building
Houston, TX 77002

:
ISIN: US03674U3005
CUSIP: 03674U300